Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases

BACKGROUND: We aimed to examine the safety and efficacy of bevacizumab and carboplatin in patients with breast cancer brain metastases. METHODS: We enrolled patients with breast cancer and > 1 measurable new or progressive brain metastasis. Patients received bevacizumab 15 mg/kg intravenously (IV...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: Leone, Jose Pablo, Emblem, Kyrre E., Weitz, Michelle, Gelman, Rebecca S., Schneider, Bryan P., Freedman, Rachel A., Younger, Jerry, Pinho, Marco C., Sorensen, A. Gregory, Gerstner, Elizabeth R., Harris, Gordon, Krop, Ian E., Morganstern, Daniel, Sohl, Jessica, Hu, Jiani, Kasparian, Elizabeth, Winer, Eric P., Lin, Nancy U.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7706261/
https://ncbi.nlm.nih.gov/pubmed/33256829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-020-01372-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados